Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates

Journal of Cystic Fibrosis

Volumn 15, Issue 4, 2016, Pages 486-494

  Amoureux, Lucie ^a   Bador, Julien ^a   Bounoua Zouak, Fatma ^a   Chapuis, Angélique ^a   de Curraize, Claire ^a   Neuwirth, Catherine ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Achromobacter spp.; Cystic fibrosis; Environment; Epidemiology; Genotyping; MLST; nNrdA

Indexed keywords

ACHROMOBACTER; ACHROMOBACTER AEGRIFACIENS; ACHROMOBACTER ANIMICUS; ACHROMOBACTER INSOLITUS; ACHROMOBACTER INSUAVIS; ACHROMOBACTER MUCICOLENS; ACHROMOBACTER SPIRITINUS; ACHROMOBACTER XYLOSOXIDANS; ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; CLONAL VARIATION; CYSTIC FIBROSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENETIC TREE; PREVALENCE; SPECIES DISTRIBUTION; SPUTUM ANALYSIS; SPUTUM CULTURE; ACHROMOBACTER DENITRIFICANS; CLASSIFICATION; ENVIRONMENTAL MICROBIOLOGY; FRANCE; GENETICS; GRAM NEGATIVE INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIGENE FAMILY; PROCEDURES; WHOLE GENOME SEQUENCING;

BACTERIAL DNA;

ACHROMOBACTER; ACHROMOBACTER DENITRIFICANS; BACTERIAL TYPING TECHNIQUES; CYSTIC FIBROSIS; DNA, BACTERIAL; ENVIRONMENTAL MICROBIOLOGY; FRANCE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MULTIGENE FAMILY; MULTILOCUS SEQUENCE TYPING; PREVALENCE; WHOLE GENOME SEQUENCING;

EID: 84953425806     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2015.12.009     Document Type: Article

References (28)

1. [1] Gomila, M., Prince-Manzano, C., Svensson-Stadler, L., Busquets, A., Erhard, M., Martinez, D.L., et al. Genotypic and phenotypic applications for the differentiation and species-level identification of Achromobacter for clinical diagnoses. PLoS One, 9, 2014, e114356.
2. [2] Ridderberg, W., Wang, M., Norskov-Lauritsen, N., Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans. J Clin Microbiol 50 (2012), 2688–2694.
3. [3] Spilker, T., Vandamme, P., Lipuma, J.J., A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter species. J Clin Microbiol 50 (2012), 3010–3015.
4. [4] Vandamme, P., Moore, E.R., Cnockaert, M., De Brandt, E., Svensson-Stadler, L., Houf, K., et al. Achromobacter animicus sp. nov., Achromobacter mucicolens sp. nov., Achromobacter pulmonis sp. nov. and Achromobacter spiritinus sp. nov., from human clinical samples. Syst Appl Microbiol 36 (2013), 1–10.
5. [5] Vandamme, P., Moore, E.R., Cnockaert, M., Peeters, C., Svensson-Stadler, L., Houf, K., et al. Classification of Achromobacter genogroups 2, 5, 7 and 14 as Achromobacter insuavis sp. nov., Achromobacter aegrifaciens sp. nov., Achromobacter anxifer sp. nov. and Achromobacter dolens sp. nov., respectively. Syst Appl Microbiol 36 (2013), 474–482.
6. [6] Spilker, T., Vandamme, P., Lipuma, J.J., Identification and distribution of Achromobacter species in cystic fibrosis. J Cyst Fibros 12 (2013), 298–301.
7. [7] Bosshard, P.P., Zbinden, R., Abels, S., Boddinghaus, B., Altwegg, M., Bottger, E.C., 16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory. J Clin Microbiol 44 (2006), 1359–1366.
8. [8] Marko, D.C., Saffert, R.T., Cunningham, S.A., Hyman, J., Walsh, J., Arbefeville, S., et al. Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting Gram-negative bacilli isolated from cultures from cystic fibrosis patients. J Clin Microbiol 50 (2012), 2034–2039.
9. [9] Amoureux, L., Bador, J., Fardeheb, S., Mabille, C., Couchot, C., Massip, C., et al. Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates. Appl Environ Microbiol 79 (2013), 7142–7149.
10. [10] Amoureux, L., Bador, J., Siebor, E., Taillefumier, N., Fanton, A., Neuwirth, C., Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data. J Cyst Fibros 12 (2013), 170–176.
11. [11] Doi, Y., Poirel, L., Paterson, D.L., Nordmann, P., Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans. Antimicrob Agents Chemother 52 (2008), 1952–1956.
12. [12] Turton, J.F., Mustafa, N., Shah, J., Hampton, C.V., Pike, R., Kenna, D.T., Identification of Achromobacter xylosoxidans by detection of the bla(OXA-114-like) gene intrinsic in this species. Diagn Microbiol Infect Dis 70 (2011), 408–411.
13. [13] Barrado, L., Branas, P., Orellana, M.A., Martinez, M.T., Garcia, G., Otero, J.R., et al. Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain. J Clin Microbiol 51 (2013), 1927–1930.
14. [14] Coward, A., Kenna, D.T., Perry, C., Martin, K., Doumith, M., Turton, J.F., Use of nrdA gene sequence clustering to estimate the prevalence of different Achromobacter species among cystic fibrosis patients in the UK. J Cyst Fibros, 2015.
15. [15] Dupont, C., Michon, A.L., Jumas-Bilak, E., Nørskov-Lauritsen, N., Chiron, R., Marchandin, H., Intrapatient diversity of Achromobacter spp. involved in chronic colonization of cystic fibrosis airways. Infect Genet Evol 32 (2015), 214–223.
16. [16] Perez-Losada, M., Cabezas, P., Castro-Nallar, E., Crandall, K.A., Pathogen typing in the genomics era: MLST and the future of molecular epidemiology. Infect Genet Evol 16 (2013), 38–53.
17. OXA-114 PCR amplification, MLST and MALDI-ToF-MS. J Clin Microbiol, 2015.
18. [18] Pereira, R.H., Carvalho-Assef, A.P., Albano, R.M., Folescu, T.W., Jones, M.C., Leao, R.S., et al. Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patients. J Clin Microbiol 49 (2011), 3649–3651.
19. [19] Edwards, U., Rogall, T., Blocker, H., Emde, M., Bottger, E.C., Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNA. Nucleic Acids Res 17 (1989), 7843–7853.
20. [20] Tenover, F.C., Arbeit, R.D., Goering, R.V., Mickelsen, P.A., Murray, B.E., Persing, D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995), 2233–2239.
21. [21] Jolley, K.A., Maiden, M.C., BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinf, 11, 2010, 595.
22. [22] Traglia, G., Papalia, M., Almuzara, M., Gutkind, G., Centron, D., Vay, C., et al. Presence of OXA-type enzymes in Achromobacter insuavis and A. dolens. Curr Microbiol 69 (2014), 501–506.
23. [23] Ridderberg, W., Bendstrup, K.E., Olesen, H.V., Jensen-Fangel, S., Nørskov-Lauritsen, N., Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment. J Cyst Fibros 10 (2011), 466–469.
24. [24] Bador, J., Amoureux, L., Blanc, E., Neuwirth, C., Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pump. Antimicrob Agents Chemother 57 (2013), 603–605.
25. [25] Bador, J., Neuwirth, C., Liszczynski, P., Mézier, M.C., Chrétiennot, M., Grenot, E., et al. Distribution of innate efflux-mediated aminoglycosides resistance among the differrent Achromobacter species. New Microbes and New Infections, 2016, 10.1016/j.nmni.2015.11.013.
26. [26] Lambiase, A., Catania, M.R., Del Pezzo, M., Rossano, F., Terlizzi, V., Sepe, A., et al. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 30 (2011), 973–980.
27. [27] Lopez-Causape, C., Rojo-Molinero, E., Mulet, X., Cabot, G., Moya, B., Figuerola, J., et al. Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection. PLoS One, 8, 2013, e71001.
28. [28] Segonds, C., Thouverez, M., Barthe, A., Bossuet-Greif, N., Tisseyre, L., Plesiat, P., et al. Development of a multiple-locus variable-number tandem-repeat typing scheme for genetic fingerprinting of Burkholderia cenocepacia and application to nationwide epidemiological analysis. J Clin Microbiol 53 (2015), 398–409.